Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AGC Chemicals to Feature Advanced Intermediates | Contract Pharma

What are you searching for?

Sign in

AGC Chemicals to Feature Advanced Intermediates

Companies fluorinated molecules serve as building blocks for pharmaceutical products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AGC Chemicals Americas will feature advanced intermediates-fluorinated molecules that serve as building blocks for pharmaceutical products-at the CPhI North America Exhibition at booth 200. AGC also will showcase its lines of fine micro-spherical silica gels for use in cosmetics, personal care, catalyst supports and specialty applications.

AGC’s extensive experience working with fluorine, chlorine and iodine chemistries enable it to produce many hard-to-synthesize molecules in commercial scale. AGC also provides contract development and manufacturing organization (CDMO) services for pharmaceutical and biopharmaceutical developers under Current Good Manufacturing Practice (cGMP) conditions.

Features of AGC’s intermediates and ingredients for pharmaceuticals include:

• Variety of fluorinated building blocks and fluorination technologies;
• Handling of HF and F2 gas directly;
• cGMP facility and API manufacturing;
• Ultra-low temperature reactions (-100 °C);
• High-quality C3 compounds (amines, alcohols, chlorides, etc.); and
• Metallocene co-catalysts.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters